Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Plos One|December 24, 2019
Second language learning induces grey matter volume increase in people with multiple sclerosisRainer Ehling, Matthias Amprosi, Benjamin Kremmel, et al.Multiple Sclerosis and Related Disorders|March 3, 2026
Development and validation of a practical documentation of inpatient rehabilitation goals, therapy content and outcomes for improving mobility in people with multiple sclerosis in Austria: A multicentre single-arm pragmatic clinical trialAndreas Wanitschek, Barbara Seebacher, Barbara Linert, et al.Journal of Neuroimmunology|October 7, 2015
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trialRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.Journal of the Neurological Sciences|February 19, 2013
Cerebellar dysfunction in a family harboring the PSEN1 mutation co-segregating with a cathepsin D variant p.A58VRainer Ehling, Lenka Nosková, Viktor Stránecký, et al.Multiple Sclerosis and Related Disorders|September 19, 2020
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter studyAlon Kalron, Rainer Ehling, Ilse Baert, et al.European Journal of Neurology|February 5, 2022
Successful long-term management of spasticity in people with multiple sclerosis using a software application: Results from a randomized, controlled, multicenter studyRainer Ehling, Barbara Seebacher, Andrea Harsányi, et al.European Journal of Physical and Rehabilitation Medicine|January 15, 2021
Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort studyBernhard Puchner, Sabina Sahanic, Rudolf Kirchmair, et al.Transfusion|April 12, 2005
Presence of RHD in serologically D-, C/E+ individuals: a European multicenter studyChristoph Gassner, Andrea Doescher, Tadeja Dovc Drnovsek, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch StudyClaudia Gneiss, Pia-Maria Koudouovoh-Tripp, Stefan Ropele, et al.Neurology|October 19, 2018
Responsiveness and meaningful improvement of mobility measures following MS rehabilitationIlse Baert, Tori Smedal, Alon Kalron, et al.Pageof 5